Keyword Analysis & Research: ptc therapeutics
Keyword Research: People who searched ptc therapeutics also searched
Search Results related to ptc therapeutics on Search Engine
-
PTC Therapeutics | Pioneers in Rare Disease Treatments
https://www.ptcbio.com/
WEBPTC Therapeutics pioneers pharmaceutical science to transform lives and treat rare diseases, like Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Huntington's Disease, Leukemia, and more.
DA: 67 PA: 85 MOZ Rank: 18
-
PTC Therapeutics, Inc. (PTCT) Stock Price, News, Quote
https://finance.yahoo.com/quote/PTCT
WEBFind the latest PTC Therapeutics, Inc. (PTCT) stock quote, history, news and other vital information to help you with your stock trading and investing.
DA: 30 PA: 97 MOZ Rank: 21
-
Our Pipeline - PTC Therapeutics
https://www.ptcbio.com/our-pipeline/
WEBApproved Medicines. To serve the rare disease community, we’ve worked tirelessly to produce treatments for multiple rare diseases. We also have a robust pipeline of product candidates to expand our impact on rare diseases and provide more moments for patients and their families.
DA: 1 PA: 46 MOZ Rank: 76
-
About PTC Therapeutics - Treatments for Rare Diseases
https://www.ptcbio.com/about-ptc/
WEBPTC is committed to providing access to best-in-class treatments for patients with little to no treatment options. This mission underpins our focus on the discovery, development, and global commercialization of clinically differentiated medicines for those with rare diseases.
DA: 71 PA: 70 MOZ Rank: 37
-
PTC Therapeutics - Wikipedia
https://en.wikipedia.org/wiki/PTC_Therapeutics
WEBPTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
DA: 66 PA: 82 MOZ Rank: 98
-
Investors | PTC Therapeutics, Inc.
https://ir.ptcbio.com/
WEBFeb 29, 2024 · Corporate Sustainability Report 2022 Report. The Investor Relations website contains information about PTC Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.
DA: 40 PA: 64 MOZ Rank: 84
-
PTC Therapeutics - The Complete History of PTC Since 1998
https://www.ptcbio.com/about-ptc/history/
WEBPTC Therapeutics was founded in 1998 focused on leveraging its expertise in RNA biology to discover and develop treatments for patients living with rare diseases. In the first 25 years, PTC achieved historic breakthroughs in the treatment of several rare diseases such as Duchenne muscular dystrophy, spinal muscular atrophy and aromatic l-amino ...
DA: 38 PA: 76 MOZ Rank: 94
-
Our Science | PTC Therapeutics
https://www.ptcbio.com/our-science/
WEBPTC is a dream team of true pioneers. We dwell at the forefront of science, endeavoring to transform lives. With intense cross-functional collaboration, unmatched expertise, and cutting-edge biotechnology platforms, we’re urgently turning the latest scientific advances into purposeful treatments.
DA: 78 PA: 38 MOZ Rank: 74
-
PTC Therapeutics Provides Corporate Update and Reports Third …
https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-provides-corporate-update-and-reports-third-1
WEBSep 30, 2023 · – PTC provides regulatory updates for pipeline programs – SOUTH PLAINFIELD, N.J., Oct. 26, 2023 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced a corporate update and financial results for the third quarter ending September 30, 2023.
DA: 36 PA: 47 MOZ Rank: 18
-
Press Releases | PTC Therapeutics, Inc.
https://ir.ptcbio.com/press-releases
WEBFeb 22, 2024 · SOUTH PLAINFIELD, N.J. , Feb. 27, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences: TD Cowen 44th Annual Health Care Conference Monday, March 4 , at 1:30 p.m.
DA: 5 PA: 95 MOZ Rank: 76